OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Extracellular Vesicles is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Genome‐Wide CRISPR/Cas9 Screening Identifies the COMMANDER Recycling Complex as a Key Player in EV Uptake	2443
Correction to "DetectEV: a Functional Enzymatic Assay to Assess Integrity and Bioactivity of Extracellular Vesicles"	306
	255
Metabolic labelling of a subpopulation of small extracellular vesicles using a fluorescent palmitic acid analogue	225
Circulating extracellular vesicles in healthy and pathological pregnancies: A scoping review of methodology, rigour and results	207
The immunomodulatory ballet of tumour‐derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD‐L1 pathway in cancer	183
Neuropathogenic role of astrocyte‐derived extracellular vesicles in HIV‐associated neurocognitive disorders	173
Arabidopsis Produces Distinct Subpopulations of Extracellular Vesicles That Respond Differentially to Biotic Stress, Altering Growth and Infectivity of a Fungal Pathogen	167
Extracellular vesicles as a promising source of lipid biomarkers for breast cancer detection in blood plasma	161
Beyond basic characterization and omics: Immunomodulatory roles of platelet‐derived extracellular vesicles unveiled by functional testing	158
Synthetic biology‐based bacterial extracellular vesicles displaying BMP‐2 and CXCR4 to ameliorate osteoporosis	156
GMP‐Compliant Process for the Manufacturing of an Extracellular Vesicles‐Enriched Secretome Product Derived From Cardiovascular Progenitor Cells Suitable for a Phase I Clinical Trial	147
Hybrid Extracellular Vesicles for Efficient Loading and Functional Delivery of mRNA	132
A new subtype of artificial cell‐derived vesicles from dental pulp stem cells with the bioequivalence and higher acquisition efficiency compared to extracellular vesicles	125
Helminth extracellular vesicles co‐opt host monocytes to drive T cell anergy	123
Glycoengineered extracellular vesicles released from antibacterial hydrogel facilitate diabetic wound healing by promoting angiogenesis	122
Extracellular vesicles from lung tissue drive bone marrow neutrophil recruitment in inflammation	121
Nanoscopic Profiling of Small Extracellular Vesicles via High‐Speed Atomic Force Microscopy (HS‐AFM) Videography	115
	109
VesicleVoyager: In Vivo Selection of Surface Displayed Proteins That Direct Extracellular Vesicles to Tissue‐Specific Targets	109
Bottom‐Up Synthesis and Purification of Extracellular Vesicle Mimetics	102
The (in)Significance of Establishing Accurate Extracellular Vesicle Nomenclature	102
Distinct molecular properties and functions of small EV subpopulations isolated from human umbilical cord MSCs using tangential flow filtration combined with size exclusion chromatography	100
Gut Microbiota‐Derived Extracellular Vesicles Influence Alcohol Intake Preferences in Rats	96
Engineered Cas9 extracellular vesicles as a novel gene editing tool	92

Imaging of surface microdomains on individual extracellular vesicles in 3‐D	87
Breast Cancer‐Derived Extracellular Vesicles Modulate the Cytoplasmic and Cytoskeletal Dynamics of Blood‐Brain Barrier Endothelial Cells	86
TMTP1‐Modified Small Extracellular Vesicles Target BRAF Mutation in Anaplastic Thyroid Cancer Reversing Vemurafenib Resistance With CRISPR/Cas9 Delivery	84
A systematic review and meta‐analysis of clinical trials assessing safety and efficacy of human extracellular vesicle‐based therapy	83
Engineering of CD63 Enables Selective Extracellular Vesicle Cargo Loading and Enhanced Payload Delivery	81
A multiantigenic antibacterial nanovaccine utilizing hybrid membrane vesicles for combating Pseudomonas aeruginosa infections	78
	77
Targeted Blockage of Pathological Extracellular Vesicles and Particles From Fibroblast‐Like Synoviocytes for Osteoarthritis Relief: Proteomic Analysis and Cellular Effect	76
	74
Correction to “Accessory ESCRT‐III proteins are conserved and selective regulators of Rab11a‐exosome formation”	73
Correction to "Microbead Encapsulation Strategy for Efficient Production of Extracellular Vesicles Derived From Human Mesenchymal Stem Cells"	73
	71
Dynamic Change of PD‐L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti‐PD‐1 Therapy	71
USP5‐Rich Apoptotic Extracellular Vesicles Regulate Nucleus Pulposus Cells Apoptosis and DNA Damage Repair by Preventing E2F1 Proteasomal Degradation	70
HIF‐1 Targeting Intervention Renders Protection From Alzheimer's‐Like Pathology in a Humanized Mice Model of HIV Infection	69
Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles	69
Extracellular Vesicle (EV) Targeted Cells Release Secondary Effector EVs: Indication of How To Account for Histocompatibility and Disease Specificity of EV Treatments	67
Extracellular vesicles and high‐density lipoproteins: Exercise and oestrogen‐responsive small RNA carriers	67
Hyaluronic acid: An overlooked extracellular vesicle contaminant	66
Phloem sap from melon plants contains extracellular vesicles that carry active proteasomes which increase in response to aphid infestation	64
Extracellular vesicle surface display of αPD‐L1 and αCD3 antibodies via engineered late domain‐based scaffold to activate T‐cell anti‐tumor immunity	62
TGF‐β regulates the release of breast cancer cell‐derived extracellular vesicles and the sorting of their protein cargo by downregulating RAB27B expression	62
MIBlood‐EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research	62
ISEV2023 Abstract Book	61
Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models	60
Five Years of EVClub—From Journal Club to Worldwide Discussion Hub	59
A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants	59
Bacterial outer membrane vesicles induce a transcriptional shift in arabidopsis towards immune system activation leading to suppression of pathogen growth in planta	59
Hypoxia and TNF‐alpha modulate extracellular vesicle release from human induced pluripotent stem cell‐derived cardiomyocytes	58
Cell‐engineered virus‐mimetic nanovesicles for vaccination against enveloped viruses	55
	55
Metastatic prostate cancer‐derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein	55